Logo, Chicago Pulmonary Specialists - Pulmonary Specialist 

 (847) 998-3434
2401 Ravine Way, Suite 302, Glenview, IL 60025

Our Philosophy         Pioneering CF Care         Private Practice        Continuity of Care      Publications          Office Policies

Diagnostics        Newborn Screening        CF Hotline        CF Testing        Sharing Our Knowledge        Advocacy       A CF Leader

   Dr. Boas        Assessing Ourselves         Home


Cutting Edge CF Research


Advancing cystic fibrosis knowledge and care has been a vital part of our mission. One of the advantages of receiving care from The Cystic Fibrosis Center of Chicago is that we are active in the worldwide CF community and participate in clinical research studies that are testing the latest treatments for CF. This includes federally-funded National Institutes of Health research as well as studies of pharmaceutical-based treatment regimens. 

Through his research efforts, Dr. Boas has been instrumental in helping to develop new and more effective treatment strategies. The lives of both those with cystic fibrosis and their families have benefited greatly from the committment of our center and of those patients with cystic fibrosis we care for.

Much of Dr. Boas’ research has been published in numerous national and international medical journals. He also lectures on his research both locally and nationally.

Independent CF Research

Quality Improvements in CF Health Care Delivery

Factors Limiting Anaerobic Exercise

Exercise Recommendation for Cystic Fibrosis

Parental Attitudes About Exercise

Energy Metabolism During Exercise

Induced Immune Modulation

Vascular Endothelial Growth Factor

Cystic Fibrosis Gene Analysis and Exercise

Vitamin D Supplementation for CF

Exercise Monitoring for CF

Training the CF Athlete

Success of Private Practice Model for CF Care

Quality Improvement in CF

Computerized Tracking for CF Care

Nationally Funded CF Research

Growth Hormone Use in CF

Genetic Modifiers

Epidemiologic Study of CF (Registry)

Stool Elastase in Patients with CF

CF Twins – Genetic Analysis

The Role of Zithromax in Cystic Fibrosis

CF and the RSV Vaccine

Exercise, Cytokines and Growth Factors

Use of Pulmozyme in Young Children with CF

CT and Inflammatory Markers in CF

Non Tuberculosis in CF

Pork Pancreatic Enzymes for CF

Non Pork Based Enzymes for CF

Inhaled Aztreonam in CF

Dry Powder Tobramycin in CF

Denufosol in CF

Inhaled Levaquin

Quality of Life during an Inhaled Antibiotic Study

Markers of Inflammation in Children with CF

Treatment of CF Related Pancreatic Insufficiency

Immune Modulation Following Exercise in CF

Inhaled Ciprofloxaacin

Use of Oral Ivacaftor for Individuals with G551D

Continuing Versus Alternating Tobramycin and Aztreonam

Inhaled Vancomycin

Anti Pseudomonal Antibody

Continuous Versus Standard Dry Powdered Tobramycin

Inhaled Mannitol